News
Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth ...
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.
The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...
With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
7d
The National on MSNHair loss and semaglutides: How GLP-1s, as well as age and genetics, can make your hair fall outIt’s a condition that’s been around as long as humans have been hirsute, but thinning hair has been making headlines over the ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Leading dentist Dr Sofina Ahmed shares how GLP-1 medications are creating visible and lasting changes to smiles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results